Ms Maria G Barzana, RPH | |
Ave. Ramon L. Rivera Bloq Za 6 Calle 36 Urb. Riverview, Bayamon, PR 00961 | |
(787) 787-4606 | |
(787) 787-4545 |
Full Name | Ms Maria G Barzana |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | Ave. Ramon L. Rivera Bloq Za 6 Calle 36 Urb. Riverview, Bayamon, Puerto Rico |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1902243348 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 4432 (Puerto Rico) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Maria G Barzana, RPH Quinta Del Rio J4 Plaza 18, Bayamon, PR 00961 Ph: (787) 385-5561 | Ms Maria G Barzana, RPH Ave. Ramon L. Rivera Bloq Za 6 Calle 36 Urb. Riverview, Bayamon, PR 00961 Ph: (787) 787-4606 |
News Archive
Ashion Analytics, a clinical laboratory of the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, is now part of the National Cancer Institute's MATCH program, which provides patients who have rare or difficult-to-treat cancers with access to unique clinical trials nationwide that might give them the best therapeutic treatments and outcomes.
The last flu season arrived four weeks early, was more intense than expected and resulted in the deaths of more than 110 children in the United States. In an effort to get ahead of the upcoming flu season, experts at Montefiore Medical Center are raising awareness about the importance of the flu vaccine, which remains the best option to reduce a person's risk of contracting the virus. The flu season can start as early as late September and usually runs for about 12 to 15 weeks.
Dendreon Corporation today reported results for the year and quarter ended December 31, 2011. Product revenue for the year ended December 31, 2011 was $213.5 million compared to $48 million for the year ended December 31, 2010. Product revenue for the fourth quarter of 2011 was $77 million compared to $25 million for the quarter ended December 31, 2010.
AVANIR Pharmaceuticals, Inc. (NASDAQ:AVNR) today announced additional detailed results from the confirmatory double-blind Phase III STAR trial evaluating two doses of the investigational drug Zenvia™ (dextromethorphan/quinidine) compared to placebo in the treatment of pseudobulbar affect (PBA) among patients with underlying multiple sclerosis (MS) or amyotrophic lateral sclerosis (ALS). Over the course of the 12-week study in the MS patient subset, Zenvia 30/10 mg met the primary efficacy endpoint by reducing PBA episode rates by an incremental 11.9% beyond placebo
ENTERPRISE THERAPEUTICS Ltd, a drug discovery company focused on new therapeutics for respiratory diseases, today announced that it has secured an additional £2.4m ($3.6m) in Series-A financing.
› Verified 1 days ago
Ms. Marissa D Cruz, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1000 Carr 167 Ste 2, Bayamon, PR 00959 Phone: 787-787-8989 | |
Milagros Cintron, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: St. Road No.2 Km 15.5, Bayamon, PR 00961 Phone: 787-474-6929 Fax: 787-474-6948 | |
Aida Iris Perez Erba, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Carr 174 Esg Calle 10 Barriojuan Sanchez, Bayamon, PR 00956 Phone: 787-798-4028 | |
Edwin Otero, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 Ave Boulevard Dr, Bayamon, PR 00959 Phone: 787-395-7480 Fax: 787-395-7482 | |
Mr. Arturo Nieves, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Ave. Orquidea #5, Reparto Valencia, Bayamon, PR 00956 Phone: 787-780-4360 | |
Leilanie Medina, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Calle Marginal #600 Urb. Flamboyam Gardens, Bayamon, PR 00956 Phone: 787-785-0411 | |
Damaris Cruz, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Sierra Bayamon 51 #30 Street 49, Bayamon, PR 00961 Phone: 787-740-8065 Fax: 787-740-8065 |